|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The prognostic value of KRAS mutated plasma DNA in advanced non-small cell lung cancer显示文摘 | Nygaard AD Garm Spindler KL Pallisgaard N | 2013 | Lung Can- cer2013，79，3： | 1 |
| 2 | Role of GTPases in control of microvascular permeability 显示文摘 | Spindler V Schlegel N Waschke J | 2010 | Cardiovasc Res2010，87，2： | 1 |
| 3 | Role of GTPases in control of microvascular permeability显示文摘 | Spindler V Schlegel N Waschke J | | 0，，02： | 1 |
| 4 | The prognostic value of KRAS mutated plasma DNA in ad-vanced non-small cell lung cancer显示文摘 | NYGAARD AD GARM SPINDLER KL PALLISGAARD N etal | 2013 | Lung Cancer2013，79，3： | 1 |
| 5 | The prognostic value of KRAS mutated plasma DNA in advanced non- small cell lung cancer显示文摘 | Nygaard AD Garm Spindler KL Pallisgaard N | 2013 | Lung Cancer2013，79，3： | 1 |
| 6 | The prognostic value of KRAS mutated plasma DNA in advanced non-small cell lung cancer显示文摘 | Nygaard AD Garm Spindler KL Pallisgaard N | 2013 | Lung Canee2013，79，： | 1 |
| 7 | Quanti- tative cell-free DNA, KRAS, and BRAF mutations in plasma from patients with metastatic colorectal cancer during treatment with cetuximab and irinotecan 显示文摘 | Spindler KL Pallisgaard N Vogelius I | 2012 | Clin Cancer Res2012，18，4： | 1 |
| 8 | Quantitative cell-free DNA, KRAS, and BRAF mutations in plasma from patients with metastatic colorectal cancer during treatment with cetuximab and irinotecan显示文摘 | Spindler KL Pallisgaard N Vogelius I | 2012 | Clinical Cancer Research2012，18，4： | 1 |
| 9 | Characterization of a discontinuous neutralizing epitope on glycoprotein B of human cytomegalovirus显示文摘 | SPINDLER N RUCKER P POTZSCH S | 2013 | Journal of Virology2013，87，16： | 1 |
| 10 | The prognostie value of kras mutated plasma DNA in advanced non-small cell lung eaneer显示文摘 | Nygaard AD Garm Spindler KL Pallisgaard N | 2013 | Lung Cancer2013，79，3： | 1 |
| 11 | Role of GTPases in control of microvascular permeability显示文摘 | Spindler V Schlegel N Waschke J | 2010 | Cardiovasc Res2010，87，2： | 1 |
| 12 | Quantitative cell-free DNA, KRAS, and BRAF mutations in plasma from patients with me- tastatic colorectal cancer during treatment with cetuximab and irino- tecan显示文摘 | Spindler KL Pallisgaard N Vogelius I | 2012 | Clin Cancer Res2012，18，： | 1 |
| 13 | Quantitative cell-free DNA,KRAS,and BRAF mutations in plasma from patients with metastatic colorectal cancer during treatment with cetuximab and irinotecan显示文摘 | Spindler K L Pallisgaard N Vogelius I | 2012 | Clin Cancer Res2012，18，4： | 1 |
| 14 | The prog- nostic value of KRAS mutated plasma DNA in advanced non-small cell lung cancer 显示文摘 | Nygaard AD Garm Spindler KL Pallisgaard N | 2013 | Lung Cancer2013，79，3： | 1 |
| 15 | Video analysis of os- motic cell response during cryo preservation 显示文摘 | Spindler R Rosenhahn B Hofmann N | 2012 | Cryobiology2012，64，： | 1 |
| 16 | Quantitative cell-free DNA, KRAS, and BRAF mutations in plasma from patients with metastatic colorectal cancer during treatment with cetuximab and irinotecan显示文摘 | Spindler KL Pallisgaard N Vogelius I | 2012 | Clin Cancer Res2012，18，4： | 1 |
| 17 | The importance of KRAS mutations and EGF61A>G polymorphism to the effect of cetuximab and irinotecan in metastatic colorectal cancer显示文摘 | Garm Spindler KL Pallisgaard N Rasmussen AA | 2009 | Ann Oncol2009，20，5： | 1 |
| 18 | Ciliated protozoa (Ciliophora) from Arctic sea ice显示文摘 | AGATHA S SPINDLER M WILBERT N | 1993 | Acta Protozool1993，32，： | 1 |
| 19 | Quantitative cell- free DNA, KRAS, and BRAF mutations in plasma from patients with metastatic coloreetal cancer during treatment with cetuximab and irinotecan 显示文摘 | Spindler KL Pallisgaard N Vogelius I | 2012 | Clin Cancer Res2012，18，4： | 1 |
| 20 | Role of GTPases in control of microvascular permeability 显示文摘 | Spindler Schlegel N Waschke J | 2010 | Cardiovasc Res2010，87，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员